doi:10.1016/S0196-9781(02)00041-4
Copyright © 2002 Elsevier Science Inc. All rights reserved.
Oxytocin stimulates proliferation of human osteoblast-like cells
References and further reading may be available for this article. To view references and further reading you must
purchase this article.
Maria Petersson, , a, Alena Lagumdzijaa, André Starkb and Elisabet Buchta
a Department of Molecular Medicine, Endocrine and Diabetes Unit, Karolinska Institutet and Karolinska Hospital, S-171 76, Stockholm, Sweden
b Department of Orthopaedics, Karolinska Institutet and Karolinska Hospital, S-171 76, Stockholm, Sweden
Received 24 October 2001;
accepted 8 January 2002.
Available online 24 May 2002.
Abstract
Oxytocin receptors have recently been demonstrated in human osteoblast-like (hOB) cells. In this study, oxytocin 100–1000 pmol/l increased cell proliferation of primary cultures of hOB cells, measured by [3H]thymidine incorporation, (P<0.01). In human osteosarcoma cell-line (SaOS-2), oxytocin 100 pmol/l increased cell proliferation (measured by [3H]thymidine incorporation and a commercially available kit) and protein synthesis ([3H]proline incorporation) (P<0.05). The increase in cell proliferation was abolished when SaOS-2 cells were incubated with an oxytocin antagonist and oxytocin. Oxytocin 100 pmol/l decreased interleukin-6 (IL-6) production of the hOB cells (23.4±1.96 versus 33.4±2.65 pg/well; P<0.001). These findings indicate that oxytocin may affect bone metabolism in humans.
Author Keywords: Oxytocin; Osteoblast; hOB cell; SaOS-2; Oxytocin antagonist; Interleukin-6
Fig. 1. DNA synthesis measured as [3H]thymidine incorporation in hOB cells incubated (a) for 72 h with 10–1000 pmol/l of oxytocin (n=9 for each concentration) or (b) for 48 h with 100 pmol/l of oxytocin (n=6). 0=control conditions (n=6). The results are shown as means±S.D. Statistical evaluation was in Fig. 1a performed by a one-way ANOVA followed by Fisher’s test for post-hoc comparisons and in Fig. 1b by Student’s t-test. ANOVA: F(3,32)=4.98, P=0.006, * P<0.05, **P<0.01.
Fig. 2. Cell proliferation of SaOS-2 cells measured by the EZ4U kit. Cells were incubated for 24 h with oxytocin 1–1000 pmol/l (n=10 for each concentration). 0=control conditions (n=10). The results are shown as means±S.D. Statistical evaluation was performed by a one-way ANOVA followed by Fisher’s test for post-hoc comparisons. ANOVA: F(4,45)=4.06, P=0.0068, * P<0.05, ** P<0.01
Fig. 3. DNA synthesis measured as [3H]thymidine incorporation in SaOS-2 cells incubated for 24 h with oxytocin 100 pmol/l (n=6) or oxytocin 100 pmol/l and the oxytocin antagonist (1-deamino-2--Tyr-(Oet)-4-Thr-8-Orn-oxytocin) 200 pmol/l (n=6). 0=control conditions (n=6). The results are shown as means±S.D. Statistical evaluation was performed by a one-way ANOVA followed by Fisher’s test for post-hoc comparisons. ANOVA: F(2,15)=3.51, P<0.05, * P<0.05.
Fig. 4. Protein synthesis measured as [3H]proline incorporation in SaOS-2 cells incubated for 24 h with oxytocin 100 pmol/l (n=6). 0=control conditions (n=6). The results are shown as means±S.D. Statistical evaluation was performed by a Student’s t-test. * P<0.05.
Fig. 5. Amount of IL-6 per well in hOB cells incubated for 48 h with oxytocin 100 pmol/l (n=6). 0=control conditions (n=6). The results are shown as means±S.D. Statistical evaluation was performed by a Student’s t-test. *** P<0.001.
Corresponding author. Tel.: +46-8-51770326; fax: +46-8-51773096; email: maria.petersson@fyfa.ki.se